Literature DB >> 33730297

Curcumin protects against inflammation and lung injury in rats with acute pulmonary embolism with the involvement of microRNA-21/PTEN/NF-κB axis.

Dean Liang1, Zhiguo Wen1, Wanli Han1, Wenming Li1, Longfei Pan2, Ruipeng Zhang3.   

Abstract

This study was intended to investigate the effect of Curcumin on acute pulmonary embolism (APE) via microRNA-21 (miR-21)/PTEN/NF-κB axis. APE model was induced on rats and administrated with Curcumin. Western blot analysis and RT-qPCR manifested the downregulation of Sp1, miR-21 and NF-κB, but the upregulation of PTEN in Curcumin-treated APE rats. Blood gas analysis, ELISA, and weighing of wet weight/dry weight (W/D) ratio indicated that Curcumin diminished mPAP and RVSP levels, W/D ratio, thrombus volume, and inflammatory factors in the lungs of APE rats. Further mechanical analysis was conducted by dual-luciferase reporter assays and ChIP assay, which showed that Sp1 increased miR-21 expression by binding to the miR-21 promoter, and that PTEN was targeted by miR-21. The APE rats were injected with adenovirus to evaluate the effect of Sp1, miR-21, or PTEN on lung injury and inflammation. It was observed that downregulation of miR-21 or Sp1, or upregulation of PTEN diminished mPAP and RVSP levels, W/D ratio, thrombus volume, and inflammatory factors in the lungs of APE rats. In summary, Curcumin decreased miR-21 expression by downregulating Sp1 to upregulate PTEN and to impair the NF-κB signaling pathway, thus suppressing lung injury and inflammation in APE rats.

Entities:  

Keywords:  Acute pulmonary embolism; Curcumin; MicroRNA-21; NF-κB signaling pathway; PTEN; Sp1

Mesh:

Substances:

Year:  2021        PMID: 33730297     DOI: 10.1007/s11010-021-04127-z

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  40 in total

1.  Curcumin ameliorates PRMT5-MEP50 arginine methyltransferase expression by decreasing the Sp1 and NF-YA transcription factors in the A549 and MCF-7 cells.

Authors:  Biji Chatterjee; Krishna Ghosh; Lavanya Suresh; Santosh R Kanade
Journal:  Mol Cell Biochem       Date:  2018-11-03       Impact factor: 3.396

Review 2.  Acute Pulmonary Embolism: With an Emphasis on an Interventional Approach.

Authors:  Wissam A Jaber; Pete P Fong; Giora Weisz; Omar Lattouf; James Jenkins; Kenneth Rosenfield; Tanveer Rab; Stephen Ramee
Journal:  J Am Coll Cardiol       Date:  2016-03-01       Impact factor: 24.094

Review 3.  Pulmonary embolism.

Authors:  Menno V Huisman; Stefano Barco; Suzanne C Cannegieter; Gregoire Le Gal; Stavros V Konstantinides; Pieter H Reitsma; Marc Rodger; Anton Vonk Noordegraaf; Frederikus A Klok
Journal:  Nat Rev Dis Primers       Date:  2018-05-17       Impact factor: 52.329

Review 4.  Curcumin, the golden spice in treating cardiovascular diseases.

Authors:  Hong Li; Antoni Sureda; Hari Prasad Devkota; Valeria Pittalà; Davide Barreca; Ana Sanches Silva; Devesh Tewari; Suowen Xu; Seyed Mohammad Nabavi
Journal:  Biotechnol Adv       Date:  2019-02-01       Impact factor: 14.227

5.  Cellular and molecular mechanisms of curcumin in prevention and treatment of disease.

Authors:  Sita Sharan Patel; Ashish Acharya; R S Ray; Ritesh Agrawal; Ramsaneh Raghuwanshi; Priyal Jain
Journal:  Crit Rev Food Sci Nutr       Date:  2019-01-11       Impact factor: 11.176

Review 6.  Anticoagulant treatment for acute pulmonary embolism: a pathophysiology-based clinical approach.

Authors:  Giancarlo Agnelli; Cecilia Becattini
Journal:  Eur Respir J       Date:  2015-02-19       Impact factor: 16.671

Review 7.  Matrix metalloproteinases as drug targets in acute pulmonary embolism.

Authors:  Evandro M Neto-Neves; Tamas Kiss; Diana Muhl; Jose E Tanus-Santos
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

Review 8.  Curcumin analogues and their hybrid molecules as multifunctional drugs.

Authors:  Sawsan A Noureddin; Reda M El-Shishtawy; Khalid O Al-Footy
Journal:  Eur J Med Chem       Date:  2019-08-19       Impact factor: 6.514

Review 9.  Curcumin and Its Derivatives as Potential Therapeutic Agents in Prostate, Colon and Breast Cancers.

Authors:  Zintle Mbese; Vuyolwethu Khwaza; Blessing Atim Aderibigbe
Journal:  Molecules       Date:  2019-11-30       Impact factor: 4.411

Review 10.  Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis.

Authors:  Christophe Marti; Gregor John; Stavros Konstantinides; Christophe Combescure; Olivier Sanchez; Mareike Lankeit; Guy Meyer; Arnaud Perrier
Journal:  Eur Heart J       Date:  2014-06-10       Impact factor: 29.983

View more
  6 in total

1.  Changes of serum P62 and Beclin 1 in patients with pulmonary embolism during treatment and their predictive value for efficacy.

Authors:  Xuehui Zhang; Liu Huang; Lijiang Shao; Xuxia Chen; Jinguo Chu; Xueqin Chen
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

Review 2.  PTEN: An Emerging Potential Target for Therapeutic Intervention in Respiratory Diseases.

Authors:  Bangrong Cai; Liu Yang; Young Do Jung; Ying Zhang; Xinguang Liu; Peng Zhao; Jiansheng Li
Journal:  Oxid Med Cell Longev       Date:  2022-06-30       Impact factor: 7.310

3.  Protective effects of lavender oil on sepsis-induced acute lung injury via regulation of the NF-κB pathway.

Authors:  Qian Xie; Yi Wang; Guo-Liang Zou
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

Review 4.  The Function of microRNAs in Pulmonary Embolism: Review and Research Outlook.

Authors:  Mingyao Luo; Mingyuan Du; Chang Shu; Sheng Liu; Jiehua Li; Lei Zhang; Xin Li
Journal:  Front Pharmacol       Date:  2021-10-19       Impact factor: 5.810

5.  Dynamic Changes in miR-21 Regulate Right Ventricular Dysfunction in Congenital Heart Disease-Related Pulmonary Arterial Hypertension.

Authors:  Wei-Ting Chang; Chia-Chun Wu; Yu-Wen Lin; Jhih-Yuan Shih; Zhih-Cherng Chen; Sheng-Nan Wu; Chia-Ching Wu; Chih-Hsin Hsu
Journal:  Cells       Date:  2022-02-06       Impact factor: 6.600

6.  Peroxiredoxin 6 mediates the protective function of curcumin pretreatment in acute lung injury induced by serum from patients undergoing one-lung ventilation in vitro.

Authors:  Hui-Ting Li; Fang Tan; Tian-Hua Zhang; Long-Hui Cao; Hong-Ying Tan; Wen-Qian Lin; Wei-An Zeng; Xin-Jin Chi
Journal:  BMC Pulm Med       Date:  2022-05-12       Impact factor: 3.320

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.